Also trades as: IPA.V (TSXV)
IPA NASDAQ
ImmunoPrecise Antibodies Ltd.
1W: -2.8%
1M: +8.9%
3M: -33.1%
1Y: +258.3%
3Y: -66.4%
5Y: -75.8%
$1.62
Last traded 2025-11-17 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$44M
-25.9% ▼
5Y CAGR: +10.3%
Total Liabilities
$21M
-20.1% ▼
5Y CAGR: +11.3%
Shareholders Equity
$24M
-30.3% ▼
5Y CAGR: +9.4%
Cash & Investments
$11M
+208.3% ▲
5Y CAGR: +32.6%
Total Debt
$13M
-2.0% ▼
5Y CAGR: +24.3%
Net Debt
$3M
-73.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $42M | $30M | $8M | $3M | $11M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $42M | $30M | $8M | $3M | $11M |
| Net Receivables | $4M | $3M | $4M | $4M | $5M |
| Inventory | $1M | $2M | $2M | $2M | $2M |
| Other Current Assets | $491K | $0 | $536K | $414K | $0 |
| Total Current Assets | $49M | $37M | $17M | $11M | $19M |
| Property, Plant & Equip. | $4M | $4M | $11M | $17M | $16M |
| Goodwill & Intangibles | $14M | $52M | $50M | $31M | $9M |
| Long-Term Investments | $111K | $142K | $115K | $63K | $91K |
| Other Non-Current Assets | $79K | $82K | $86K | $498K | $35K |
| Total Non-Current Assets | $18M | $56M | $61M | $49M | $26M |
| Total Assets | $67M | $93M | $78M | $60M | $44M |
| — Liabilities — | |||||
| Accounts Payable | $1M | $4M | $2M | $4M | $5M |
| Short-Term Debt | $801K | $1M | $823K | $1M | $1M |
| Deferred Revenue | $0 | $1M | $977K | $0 | $1M |
| Other Current Liabilities | $1M | $1M | -$384K | $1M | -$1M |
| Total Current Liabilities | $6M | $9M | $6M | $8M | $9M |
| Long-Term Debt | $2M | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $1M | $497K | $278K | $6M | $0 |
| Total Non-Current Liabilities | $4M | $9M | $14M | $18M | $12M |
| Total Liabilities | $10M | $18M | $20M | $26M | $21M |
| — Equity — | |||||
| Common Stock | $80M | $115M | $117M | $120M | $136M |
| Retained Earnings | -$30M | -$47M | -$73M | -$100M | -$129M |
| Accumulated OCI | -$687K | -$2M | $3M | $2M | $3M |
| Total Stockholders Equity | $57M | $75M | $58M | $34M | $24M |
| Total Liabilities & Equity | $67M | $93M | $78M | $60M | $44M |
| — Key Metrics — | |||||
| Total Debt | $3M | $3M | $7M | $14M | $13M |
| Net Debt | -$38M | -$27M | -$1M | $10M | $3M |
| Total Investments | $111K | $142K | $115K | $63K | $91K |